紫锥菊的组织培养和植株再生

1植物名称紫锥菊(Echinacea purpurea),又名紫松果菊. 2材料类别无菌苗的叶柄切段. 3培养条件(1)芽诱导及增殖培养基:MS 6-BA 1.0mg·L-1(单位下同) NAA 0.5 3%蔗糖 0.7%琼脂,pH 6.0;(2)生根培养基:B5大量元素 MS微量元素、铁盐、有机物 NAA 1.0 2%蔗糖 0.9%琼脂,pH 6.0.培养温度为(25 1)℃,光照12 h·d-1,光照度1500～2000 lx.     

紫锥菊多倍体诱导与鉴定

本实验以紫锥菊愈伤组织上刚分化出的不定芽为材料,用不同浓度秋水仙素溶液对其进行诱导,确定最佳处理浓度和处理时间,并对诱导的多倍体与二倍体进行形态、显微、染色体及过氧化氢酶(CAT)活性的比较鉴定.结果表明:0.025%秋水仙素浓度处理24h的诱导效果最好,诱导率达42.85%;多倍体植株叶片肥厚、根粗壮,气孔面积极显著地大于二倍体植株,染色体数从24～28条不等,CAT平均酶活性是二倍体的2.1倍.     

紫锥菊的生药学研究

采用来源鉴定、性状鉴定、显微及理化鉴定的方法研究紫锥菊的生药学内容,为制定药材质量标准、研究、开发和利用紫锥菊的药用资源提供了理论依据。     

紫锥菊挥发性成分分析研究

采用气-质(GC-MS)联用技术结合顶空固相微萃取(HS-SPME)与传统共水蒸馏法,对紫锥菊植物干花与干根中挥发性成分进行分析方法研究。GC-MS(配N ist2005标准质谱库)从传统方法提取的紫锥菊干根挥发油中分离分析出188个峰,初步鉴定出68种化合物,从聚二甲基硅氧烷(PDMS 7,100μm)及聚丙烯酸酯(PA 85μm)三种固相微萃取涂层吸附的紫锥菊干花挥发性成分中分别分离分析出27、118、105个峰,各自鉴定出1、22、23种化合物。对不同处理方法及紫锥菊植物不同部位所得数据进行了相识性与差异性的比较,所建分析方法及所得结果为了解紫锥菊植物体挥发性有效成分提供了参考。     

无机盐和蔗糖浓度对白色紫锥菊不定根生长及次生代谢产物积累影响

利用组织培养技术结合高效液相色谱法,考察了液体悬浮培养中无机盐和蔗糖浓度对白色紫锥菊不定根生长以及紫锥菊苷、菊苣酸、氯原酸和酚类化合物积累的影响.结果表明:白色紫锥菊不定根在高或低浓度无机盐和蔗糖培养基中的生长及次生代谢产物含量均较低,不定根生长最适培养基为0.75 MS +5％蔗糖,培养30 d后不定根中紫锥菊苷含量为7.40 mg/g DW,菊苣酸为3.96 mg/g DW,氯原酸含量达3.79 mg/g DW,总酚含量达25.62 mg/g DW.本研究为进一步大规模培养富含紫锥菊苷、菊苣酸的白色紫锥菊不定根奠定了理论和实践基础.     

紫锥菊多糖抑制致病性大肠埃希菌细胞黏附的试验研究

目的研究紫锥菊多糖能否影响致病性大肠埃希菌对细胞的黏附。方法使用PK-15细胞进行黏附试验及黏附抑制试验。结果发现紫锥菊多糖浓度为1.6 mg/ml时,对细菌黏附细胞的抑制作用最好,黏附率由50个细菌/细胞降低到6.8个细菌/细胞。结论紫锥菊多糖对致病性大肠埃希菌的细胞黏附具有抑制作用,提示该多糖具有调节肠道微生态的潜在应用价值。     

紫锥菊愈伤组织诱导及生物活性成分分析

以紫锥菊(Echinacea purpurea)无菌苗为材料,研究了不同激素配比条件下不同外值体愈伤组织的诱导及所诱导的愈伤组织中的主要成分多糖和总酚,并应用高效液相色谱法对根愈伤组织提取物与紫锥菊根提取物中的酚酸类物质进行了比较分析.结果表明,紫锥菊不同部位愈伤组织诱导的最适宜激素配比不同,其中根愈伤组织诱导的最佳激素配比为0.5 mg/L 2,4-D 0.5 mg/L 6-BA.叶、茎、根诱导愈伤组织的多糖含量分别为10.15、11.84、14.49 mg/g干重;总酚含量分别为52.16、28.144、7.99 mg/g干重.根愈伤组织总酚和多糖含量均较高,其提取物的酚酸类物质的高效液相色谱与紫锥菊根提取物图谱主峰一致,且生长速度快、质地疏松,是细胞培养获取紫锥菊主要生物活性成分的适宜材料.     

紫锥菊提取物及酚酸化合物体外抗血小板聚集活性研究

为探究紫锥菊提取物及酚酸化合物体外抗血小板聚集活性,体外抗血小板聚集实验采用Born比浊法,以聚集抑制率和半数抑制浓度为指标评价。同时采用分子对接方法,选择凝血因子V(F5)、凝血因子VIII(F8)及凝血因子XI(F11)与酚酸类化合物进行虚拟对接,研究其抗血小板聚集的分子作用靶点。结果表明化合物S-1～S-10及其提取物对体外ADP诱导的血小板聚集有抑制作用,抑制率呈浓度依赖性,S-6与靶点的结合位点更多,选择性更强。紫锥菊中酚酸类化合物及其提取物在体外均显现出抗ADP诱导的血小板聚集活性,为紫锥菊体内研究提供依据。     

紫锥菊单咖啡酰酒石酸和菊苣酸提取工艺优化

采用正交试验设计,选取乙醇体积浓度百分比、提取温度、提取时间、抗氧化剂用量等因素,优化紫锥菊Echinacea purpurea单咖啡酰酒石酸和菊苣酸的加热回流提取工艺,并考察加入抗氧化剂对提取效果的影响。结果表明,优化的提取条件是以25%乙醇,在80 ℃回流提取90 min。抗氧化剂用量对提取效果影响不显著。优化后的加热回流提取条件对紫锥菊单咖啡酰酒石酸和菊苣酸的提取均适用,提取中无需加入抗氧化剂。     

大孔吸附树脂对紫锥菊提取物中菊苣酸分离纯化的研究

采用大孔吸附树脂分离纯化紫锥菊提取物中免疫活性成分菊苣酸,7％(v／v)的甲醇-水溶液洗脱,HPLC法对产品中菊苣酸含量进行检测分析。该法能把紫锥菊提取物中菊苣酸含量(4％)提高9倍左右,回收率达到95％以上,且操作简单,可用于菊苣酸的分离纯化。     

三种药用植物内生真菌抗真菌活性的研究

从雪上一枝蒿(Aconitumbrachypodum)、刺五加(Acanthopanaxsenticosus)和大血藤(Sargentodoxacuneata)分离获得的162株内生真菌进行抗真菌活性检测,结果具有抗菌活性菌株有74株,雪上一枝蒿15株,刺五加23株,大血藤36株,分别占3种植物各自内生真菌的44.12%,48.94%和44.44%。将具有抗菌活性的菌株进行分类鉴定,分属于6目、7科、23属。     

Plant Regeneration from Mesophyll Protoplasts of Echinacea Purpurea

An efficient plant regeneration system was developed from isolated protoplasts of Echinacea purpurea L. using an alginate block/liquid culture system. Viable protoplasts could be routinely isolated from young leaves of Echinacea seedlings in an isolation mixture containing 1.0% cellulase Onozuka R-10, 0.5% pectinase and 0.3 mol l^–1 mannitol. Purified protoplasts were embedded in 0.6% Na-alginate block at a density of 1 × 10⁵/ml and cultured in a modified MS medium containing 0.3 mol l^–1 sucrose, 2.5 µmol l^–1 BA and 5.0 µmol l^–1 2,4-D. Cell colonies were observed after 4 weeks of culture, and the protoplast-derived colonies formed calluses when transferred onto 0.25% gellan gum-solidified MS medium supplemented with 1.0 µmol l^–1 BA and 2.0 µmol l^–1 IBA. Shoot organogenesis from protoplast-derived callus was induced on MS medium supplemented with 5.0 µmol l^–1 BA and 2.0 µmol l^–1 IBA. Complete plantlets were obtained from the regenerated shoots on MS basal medium. The protoplast to plant regeneration protocol developed in this study provides the prerequisite for creating novel genotypes of this valuable medicinal species through genetic manipulation.     

Proliferative activity of Echinacea angustifolia root extracts on cancer cells: Interference with doxorubicin cytotoxicity

Doxorubicin is an anticancer drug that causes apoptosis in cells, but cardiotoxicity limits the cumulative dose that can remain in the blood. Echinacea extracts have been prescribed to supplement cancer chemotherapy. In a recent study, it was reported that Echinacea purpurea extracts protected noncancerous cells from apoptosis. Our study aimed to determine interference with doxorubicin chemotherapy, and if fractions and compounds from Echinacea angustifolia roots protected the cells. Cervical and breast cancer cells were treated with the Echinacea samples and doxorubicin. At 0.05 and 0.5 microM doxorubicin concentration, cynarine increased HeLa cell growth by 48-125% and 29-101%, respectively (p<0.01). At 0.05 microM doxorubicin concentration, chicoric acid increased cell growth by 23-100% (p<0.01). When MCF-7 cells were treated with Echinacea and doxorubicin, the ethyl acetate fraction increased cell growth by 20-25%, and chicoric acid increased cell growth by 10-15%. Cynarine showed proliferative activity on HeLa cells, but showed antiproliferative activity on MCF-7 cells. Results indicate that phenolic compounds are responsible for proliferative activity. Studies with individual compounds show that chicoric acid and cynarine interfered with cells treated with 0.5 microM doxorubicin. The results of this study show that Echinacea herbal medicines affect cell proliferation despite cancer treatment, and that herbal medicines require further study with respect to anticancer drugs.     

Designing Alginate/Chitosan Nanoparticles Containing Echinacea angustifolia: A Novel Candidate for Combating Multidrug-Resistant Staphylococcus aureus

Nanoparticles (NPs) may help treat multidrug-resistant Staphylococcus aureus (MDR). This study prepared and evaluated chitosan/alginate-encapsulated Echinacea angustifolia extract against MDR strains. Evaluating synthesized NPs with SEM, DLS, and FT-IR. Congo red agar and colorimetric plate techniques examined isolate biofilm formation. NP antibacterial power was assessed using well diffusion. Real-time PCR assessed biofilm-forming genes. MTT assessed the synthesized NPs′ toxicity. According to DLS measurements, spherical E. angustifolia NPs had a diameter of 335.3±1.43 nm. The PDI was 0.681, and the entrapment effectiveness (EE%) of the E. angustifolia extract reached 83.45 %. Synthesized NPs were most antimicrobial. S. aureus resistant to several treatments was 80 percent of 100 clinical samples. Biofilm production was linked to MDR in all strains. The ALG/CS-encapsulated extract had a 4 to 32-fold lower MIC than the free extract, which had no bactericidal action. They also significantly decreased the expression of genes involved in biofilm formation. E. angustifolia-encapsulated ALG/CS decreased IcaD, IcaA, and IcaC gene expression in all MDR strains (***p<0.001). Free extract, free NPs, and E. angustifolia-NPs had 57.5 %, 85.5 %, and 90.0 % cell viability at 256 μg/ml. These discoveries could assist generate stable plant extracts by releasing natural-derived substances under controlled conditions.     

江珧活性蛋白的分离及抗氧化作用研究

采用匀浆、硫酸铵分级沉淀和Sephadex G-100柱层析的方法从江珧的闭壳肌及内脏团分别分离到3个和2个活性蛋白峰,经化学发光法进行体外抗氧化测定,这些活性蛋白都具有清除超氧阴离子自由基、羟自由基、过氧化氢和抑制脂质过氧化作用,其中闭壳肌第三个蛋白峰(PB3)与内脏团第二个蛋白峰(PN2)抑制能力最强。     

刺梨黄酮的体外抗氧化作用

利用化学发光及分光光度法研究了刺梨黄酮对活性氧自由基O2-.,H2O2,DPPH·的清除作用,以及对H2O2诱导的红细胞氧化溶血和肝组织脂质过氧化产物(MDA)形成的抑制作用。结果表明,刺梨黄酮能很好地清除各种活性氧,并能显著抑制红细胞氧化溶血以及肝组织MDA的产生。提示其是一种很好的抗氧化剂。     

Isolation and structure elucidation of cytotoxic polyacetylenes and polyenes from Echinacea pallida

Bioassay-guided fractionation of n-hexane extracts of Echinacea pallida (Asteraceae) roots led to the isolation and structure elucidation of two polyacetylenes (1, 3) and three polyenes (2, 4, 5). Two are known hydroxylated compounds, namely 8-hydroxy-pentadeca-(9E)-ene-11,13-diyn-2-one (1) and 8-hydroxy-pentadeca-(9E,13Z)-dien-11-yn-2-one (2). Two dicarbonylic constituents, namely pentadeca-(9E)-ene-11,13-diyne-2,8-dione (3) and pentadeca-(9E,13Z)-dien-11-yne-2,8-dione (4), were isolated and characterized for the first time. Furthermore, the structure elucidation of pentadeca-(8Z,13Z)-dien-11-yn-2-one (5) is described. The structure of the compounds isolated was determined on the basis of UV, IR, NMR (including 1D and 2D NMR experiments, such as 1H-1H gCOSY, gHSQC-DEPT, gHMBC, gNOESY) and MS spectroscopic data. The cytotoxic activity of the isolated constituents against MIA PaCa-2 human pancreatic adenocarcinoma cells was evaluated in the concentration range 1-100 microg/ml. Results show that the hydroxylated compounds (1, 2) have low cytotoxicity, while the more hydrophobic polyacetylenes (3) and polyenes (4, 5) displayed moderate activity.     

Physicochemical Characteristics, Cytotoxicity, and Antioxidant Activity of Three Lipid Nanoparticulate Formulations of Alpha-lipoic Acid

Exogenously supplied alpha-lipoic acid (LA) has proven to be effective as an antioxidant. In an effort to develop a water-soluble formulation for topical administration, LA was formulated in the form of solid lipid nanoparticles (SLN), nanostructure lipid carriers (NLC), and nanoemulsion (NE) and characterized in terms of physical and biological properties. Mean particle size of 113, 110, and 121 nm were obtained for NE, NLC, and SLN, respectively, with narrow size distribution. Zeta potential was approximately in the range of −25 to −40 mV. Disc and spherical structures of nanoparticles were observed by cryo-scanning electron microscopy. Entrapment efficiency of LA in three formulations was found to be more than 70%. After 120 days of storage at 25°C, physical stability of all formulations remained unchanged whereas the entrapment efficiency of SLN and NLC could be maintained, suggesting relative long-term stability. Prolonged release of LA formulation following the Higuchi model was found where a faster release was observed from NE compared with that of SLN and NLC. More than 80% of cell survivals were found up to 1 μM of LA concentrations. Antioxidant activity analysis demonstrated that all LA-loaded formulations expressed antioxidant activity at a similar magnitude as pure LA. These results suggest that chosen compositions of lipid nanoparticles play an important role on drug loading, stability, and biological activity of nanoparticles. Both SLN and NLC demonstrated their potential as alternative carriers for aqueous topical administration of LA.